Desmoglein-1, differentiation, and disease

Journal of Clinical Investigation

Volumn 123, Issue 4, 2013, Pages 1419-1422

  Hammers, Christoph M ^a   Stanley, John R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 1; RAF PROTEIN; RAS PROTEIN;

ANTIBODY PRODUCTION; CELL ADHESION; CELL DIFFERENTIATION; EPIDERMIS; HUMAN; KERATINOCYTE; KERATODERMA; MOLECULAR CLONING; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION; REVIEW; SIGNAL TRANSDUCTION; SKIN DISEASE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL DIFFERENTIATION; DESMOGLEIN 1; EPIDERMIS; FEMALE; HUMANS; KERATINOCYTES; MALE; MAP KINASE SIGNALING SYSTEM;

EID: 84875869664     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69071     Document Type: Review

References (22)

1. Steinberg MS, Shida H, Giudice GJ, Shida M, Patel NH, Blaschuk OW. On the molecular organization, diversity and functions of desmosomal proteins. Ciba Found Symp. 1987;125:3-25.
2. Schafer S, Koch PJ, Franke WW. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of a subfamily of desmosomal cadherins. Exp Cell Res. 1994;211(2):391-399.
3. Bornslaeger EA, et al. Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cell-cell borders. J Cell Sci. 2001;114(pt 4):727-738.
4. Korman NJ, Eyre RW, Klaus-Kovtun V, Stanley Jr. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med. 1989;321(10):631-635.
5. Kowalczyk AP, et al. The head domain of plakophilin-1 binds to desmoplakin and enhances its recruitment to desmosomes. Implications for cutaneous disease. J Biol Chem. 1999;274(26):18145-18148.
6. Koch PJ, Franke WW. Desmosomal cadherins: Another growing multigene family of adhesion molecules. Curr Opin Cell Biol. 1994;6(5):682-687.
7. Harmon RM, et al. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation. J Clin Invest. 2013; 123(4):1556-1570.
8. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and staphylococcal scalded skin syndrome. N Engl J Med. 2006;355(17):1800-1810.
9. Ishii K, Lin C, Siegel DL, Stanley Jr. Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol. 2008; 128(4):939-948.
10. Wu H, et al. Protection of neonates against pemphigus foliaceus by desmoglein 3. N Engl J Med. 2000; 343(1):31-35.
11. Elias PM, et al. Desmoglein isoform distribution affects stratum corneum structure and function. J Cell Biol. 2001;153(2):243-249.
12. Brennan D, et al. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci. 2007;120(pt 5):758-771.
13. Getsios S, et al. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol. 2009; 185(7):1243-1258.
14. Rickman L, et al. N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet. 1999;8(6):971-976.
15. Wan H, et al. Striate palmoplantar keratoderma arising from desmoplakin and desmoglein 1 mutations is associated with contrasting perturbations of desmosomes and the keratin filament network. Br J Dermatol. 2004;150(5):878-891.
16. Lebeau S, et al. Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol. 2005; 152(6):1248-1255.
17. Matsunaga-Udagawa R, et al. The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf. J Biol Chem. 2010;285(10):7818-7826.
18. Siegel DH, Mann JA, Krol AL, Rauen KA. Dermatological phenotype in Costello syndrome: Consequences of Ras dysregulation in development. Br J Dermatol. 2012;166(3):601-607.
19. Nava C, et al. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: Genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007;44(12):763-771.
20. McGrath JA. Inherited disorders of desmosomes. Australas J Dermatol. 2005;46(4):221-229.
21. Dusek RL, Attardi LD. Desmosomes: New perpetrators in tumour suppression. Nat Rev Cancer. 2011; 11(5):317-323.
22. Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T. Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol. 2000; 27(1):24-29.